Summaries for patients. Bone loss after stopping estrogen or alendronate therapy
- PMID: 12459003
- DOI: 10.7326/0003-4819-137-11-200212030-00003
Summaries for patients. Bone loss after stopping estrogen or alendronate therapy
Original report in
-
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.Ann Intern Med. 2002 Dec 3;137(11):875-83. doi: 10.7326/0003-4819-137-11-200212030-00008. Ann Intern Med. 2002. PMID: 12458987 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical